Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, Antigen, T-Cell | 50 | 2023 | 2549 | 4.780 |
Why?
|
Histocompatibility Antigens Class II | 24 | 2019 | 1445 | 2.920 |
Why?
|
HLA-D Antigens | 11 | 2013 | 134 | 2.360 |
Why?
|
Killer Cells, Natural | 15 | 2024 | 2203 | 2.260 |
Why?
|
Antigen Presentation | 19 | 2019 | 1254 | 2.170 |
Why?
|
T-Lymphocytes | 58 | 2023 | 10191 | 2.150 |
Why?
|
Histocompatibility Antigens Class I | 17 | 2024 | 1355 | 2.110 |
Why?
|
Peptides | 30 | 2014 | 4342 | 1.920 |
Why?
|
HLA-DR2 Antigen | 17 | 2011 | 47 | 1.850 |
Why?
|
CD8-Positive T-Lymphocytes | 24 | 2024 | 4576 | 1.810 |
Why?
|
T-Lymphocytes, Cytotoxic | 11 | 2020 | 1783 | 1.730 |
Why?
|
Autoantigens | 17 | 2013 | 892 | 1.620 |
Why?
|
CD4-Positive T-Lymphocytes | 22 | 2024 | 4371 | 1.580 |
Why?
|
Immunotherapy | 25 | 2024 | 4649 | 1.460 |
Why?
|
Autoimmunity | 16 | 2018 | 1355 | 1.430 |
Why?
|
Antigens, Neoplasm | 12 | 2022 | 1994 | 1.240 |
Why?
|
Histocompatibility Antigens | 5 | 2014 | 467 | 1.210 |
Why?
|
Immunological Synapses | 4 | 2017 | 59 | 1.160 |
Why?
|
Lymphocyte Activation | 31 | 2023 | 5491 | 1.150 |
Why?
|
Neoplasms | 21 | 2024 | 22158 | 1.100 |
Why?
|
Multiple Sclerosis | 28 | 2018 | 3222 | 1.020 |
Why?
|
Tumor Escape | 4 | 2021 | 370 | 1.020 |
Why?
|
Autoimmune Diseases | 16 | 2014 | 2248 | 1.000 |
Why?
|
Cell Membrane | 9 | 2016 | 3687 | 0.990 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily B | 2 | 2024 | 84 | 0.960 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 3 | 2018 | 317 | 0.960 |
Why?
|
HLA-DR Antigens | 12 | 2009 | 631 | 0.950 |
Why?
|
Amino Acid Sequence | 57 | 2018 | 13446 | 0.930 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 9 | 2022 | 1089 | 0.920 |
Why?
|
B-Lymphocytes | 16 | 2020 | 4764 | 0.880 |
Why?
|
Melanoma | 10 | 2023 | 5706 | 0.880 |
Why?
|
Immunity, Cellular | 4 | 2024 | 1560 | 0.870 |
Why?
|
Cytokines | 14 | 2023 | 7390 | 0.870 |
Why?
|
Receptor-CD3 Complex, Antigen, T-Cell | 5 | 2010 | 67 | 0.870 |
Why?
|
Myelin-Associated Glycoprotein | 3 | 2009 | 107 | 0.860 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily K | 8 | 2024 | 95 | 0.840 |
Why?
|
Melanoma, Experimental | 5 | 2018 | 560 | 0.830 |
Why?
|
Major Histocompatibility Complex | 4 | 2014 | 927 | 0.820 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 14 | 2010 | 800 | 0.810 |
Why?
|
Receptors, Immunologic | 8 | 2010 | 1412 | 0.800 |
Why?
|
Molecular Sequence Data | 56 | 2013 | 17640 | 0.800 |
Why?
|
Peptide Fragments | 29 | 2012 | 5114 | 0.800 |
Why?
|
Skin Diseases, Genetic | 1 | 2022 | 49 | 0.770 |
Why?
|
Antigens | 5 | 2020 | 1446 | 0.750 |
Why?
|
SOXC Transcription Factors | 1 | 2020 | 41 | 0.740 |
Why?
|
Animals | 118 | 2024 | 168388 | 0.730 |
Why?
|
Models, Molecular | 22 | 2018 | 5439 | 0.720 |
Why?
|
Epitopes, T-Lymphocyte | 9 | 2019 | 825 | 0.720 |
Why?
|
Autoantibodies | 10 | 2015 | 2123 | 0.700 |
Why?
|
Protein-Arginine N-Methyltransferases | 1 | 2021 | 129 | 0.700 |
Why?
|
Mice | 86 | 2024 | 81474 | 0.690 |
Why?
|
Fluorescence Resonance Energy Transfer | 4 | 2017 | 420 | 0.690 |
Why?
|
Signal Transduction | 22 | 2023 | 23427 | 0.690 |
Why?
|
Encephalomyelitis, Acute Disseminated | 3 | 2015 | 68 | 0.670 |
Why?
|
Databases, Protein | 1 | 2021 | 388 | 0.660 |
Why?
|
Tumor Microenvironment | 13 | 2023 | 3873 | 0.660 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2021 | 512 | 0.660 |
Why?
|
Glioblastoma | 8 | 2023 | 3482 | 0.650 |
Why?
|
Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 2 | 2016 | 93 | 0.650 |
Why?
|
Immunologic Memory | 8 | 2024 | 1359 | 0.640 |
Why?
|
Diabetes Mellitus, Type 1 | 14 | 2017 | 3441 | 0.640 |
Why?
|
HLA-DQ Antigens | 7 | 2011 | 211 | 0.620 |
Why?
|
Antibodies, Monoclonal | 10 | 2024 | 9180 | 0.600 |
Why?
|
Glioma | 3 | 2022 | 3455 | 0.590 |
Why?
|
Antibodies, Blocking | 1 | 2018 | 243 | 0.580 |
Why?
|
Myeloid Cells | 2 | 2020 | 823 | 0.580 |
Why?
|
Cytotoxicity, Immunologic | 5 | 2024 | 1351 | 0.580 |
Why?
|
Arenaviridae Infections | 1 | 2017 | 53 | 0.570 |
Why?
|
Receptors, Chemokine | 1 | 2020 | 653 | 0.560 |
Why?
|
Integrins | 2 | 2020 | 834 | 0.560 |
Why?
|
HLA-A Antigens | 4 | 2013 | 226 | 0.550 |
Why?
|
Myelin Proteins | 4 | 2009 | 209 | 0.550 |
Why?
|
Histone Deacetylases | 2 | 2021 | 719 | 0.540 |
Why?
|
Cell Line, Tumor | 25 | 2024 | 16966 | 0.530 |
Why?
|
T-Lymphocytes, Regulatory | 9 | 2020 | 3075 | 0.510 |
Why?
|
Humans | 186 | 2024 | 761326 | 0.490 |
Why?
|
Mice, Inbred NOD | 14 | 2020 | 1825 | 0.480 |
Why?
|
Immunodominant Epitopes | 10 | 2007 | 240 | 0.480 |
Why?
|
Neoplasm Metastasis | 3 | 2019 | 4908 | 0.470 |
Why?
|
Protein Binding | 22 | 2018 | 9351 | 0.450 |
Why?
|
HLA-DR1 Antigen | 2 | 2012 | 12 | 0.440 |
Why?
|
Chromosomal Proteins, Non-Histone | 2 | 2020 | 726 | 0.440 |
Why?
|
Membrane Lipids | 2 | 2012 | 252 | 0.440 |
Why?
|
Vaccines | 1 | 2022 | 837 | 0.440 |
Why?
|
Dimerization | 10 | 2010 | 891 | 0.430 |
Why?
|
Cyclin-Dependent Kinase 4 | 4 | 2021 | 559 | 0.430 |
Why?
|
Gene Expression Regulation, Neoplastic | 9 | 2023 | 8527 | 0.420 |
Why?
|
Cyclin-Dependent Kinase 6 | 3 | 2021 | 347 | 0.420 |
Why?
|
Nitric Oxide | 2 | 2021 | 2133 | 0.410 |
Why?
|
Epitope Mapping | 2 | 2013 | 297 | 0.410 |
Why?
|
Single-Cell Analysis | 7 | 2021 | 2448 | 0.410 |
Why?
|
Ligands | 9 | 2022 | 3271 | 0.410 |
Why?
|
T-Lymphocyte Subsets | 8 | 2021 | 1805 | 0.410 |
Why?
|
Viral Proteins | 5 | 2013 | 1803 | 0.410 |
Why?
|
Hematologic Neoplasms | 1 | 2024 | 1896 | 0.400 |
Why?
|
Myelodysplastic Syndromes | 1 | 2022 | 1394 | 0.400 |
Why?
|
Protein Phosphatase 2 | 1 | 2014 | 231 | 0.390 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 2 | 2010 | 346 | 0.390 |
Why?
|
Genes, MHC Class II | 4 | 2004 | 451 | 0.390 |
Why?
|
Colitis | 1 | 2020 | 1231 | 0.390 |
Why?
|
Jurkat Cells | 4 | 2017 | 739 | 0.380 |
Why?
|
Mice, Inbred C57BL | 23 | 2022 | 22154 | 0.380 |
Why?
|
Protein Structure, Tertiary | 11 | 2018 | 3792 | 0.380 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 10 | 2018 | 822 | 0.370 |
Why?
|
Immunomodulation | 3 | 2020 | 547 | 0.370 |
Why?
|
Genes, MHC Class I | 2 | 2023 | 240 | 0.360 |
Why?
|
Epitopes | 11 | 2021 | 2504 | 0.360 |
Why?
|
Cross Reactions | 10 | 2018 | 818 | 0.360 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2021 | 2911 | 0.350 |
Why?
|
Lung Neoplasms | 4 | 2024 | 13333 | 0.350 |
Why?
|
Molecular Mimicry | 4 | 2001 | 213 | 0.340 |
Why?
|
Head and Neck Neoplasms | 1 | 2024 | 2891 | 0.330 |
Why?
|
Drug Resistance, Neoplasm | 6 | 2021 | 5297 | 0.320 |
Why?
|
Neuromyelitis Optica | 2 | 2015 | 263 | 0.320 |
Why?
|
Membrane Proteins | 9 | 2018 | 7852 | 0.320 |
Why?
|
Mutant Proteins | 1 | 2010 | 491 | 0.320 |
Why?
|
Crystallography, X-Ray | 8 | 2013 | 1990 | 0.320 |
Why?
|
Protein Conformation | 9 | 2012 | 3969 | 0.310 |
Why?
|
Inflammation | 5 | 2021 | 10760 | 0.300 |
Why?
|
Viral Matrix Proteins | 2 | 2020 | 196 | 0.300 |
Why?
|
Sequence Alignment | 8 | 2018 | 2180 | 0.300 |
Why?
|
Lymphocytic choriomeningitis virus | 2 | 2020 | 178 | 0.300 |
Why?
|
Superantigens | 4 | 2007 | 127 | 0.290 |
Why?
|
RNA Interference | 1 | 2016 | 2832 | 0.290 |
Why?
|
HLA-B27 Antigen | 2 | 2004 | 63 | 0.290 |
Why?
|
Clone Cells | 15 | 2020 | 1661 | 0.290 |
Why?
|
Molecular Targeted Therapy | 2 | 2021 | 2811 | 0.280 |
Why?
|
Mice, Transgenic | 21 | 2021 | 9534 | 0.280 |
Why?
|
Thymus Gland | 5 | 2011 | 1241 | 0.280 |
Why?
|
Sequence Analysis, RNA | 5 | 2021 | 2019 | 0.280 |
Why?
|
Epigenesis, Genetic | 1 | 2020 | 3793 | 0.270 |
Why?
|
Herpesvirus 4, Human | 5 | 2020 | 1079 | 0.270 |
Why?
|
Cancer Vaccines | 5 | 2021 | 1050 | 0.270 |
Why?
|
HLA Antigens | 4 | 2019 | 1371 | 0.270 |
Why?
|
Immunotherapy, Adoptive | 5 | 2023 | 1469 | 0.260 |
Why?
|
Human T-lymphotropic virus 1 | 4 | 2007 | 142 | 0.260 |
Why?
|
Tetracycline | 1 | 2006 | 219 | 0.260 |
Why?
|
Structure-Activity Relationship | 6 | 2010 | 3076 | 0.260 |
Why?
|
Immune Tolerance | 5 | 2017 | 2300 | 0.260 |
Why?
|
Chemokines | 2 | 2020 | 960 | 0.260 |
Why?
|
Binding Sites | 11 | 2013 | 6052 | 0.250 |
Why?
|
Models, Immunological | 4 | 2007 | 512 | 0.250 |
Why?
|
Bacterial Proteins | 4 | 2018 | 3847 | 0.250 |
Why?
|
Cell Separation | 1 | 2011 | 1722 | 0.250 |
Why?
|
Viremia | 2 | 2005 | 707 | 0.250 |
Why?
|
MicroRNAs | 3 | 2017 | 3796 | 0.250 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2024 | 5303 | 0.250 |
Why?
|
Flow Cytometry | 11 | 2020 | 5866 | 0.250 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2020 | 3590 | 0.250 |
Why?
|
Receptors, Fc | 2 | 2023 | 535 | 0.250 |
Why?
|
Mice, Knockout | 11 | 2020 | 14409 | 0.240 |
Why?
|
Central Nervous System | 4 | 2011 | 1337 | 0.240 |
Why?
|
Lectins, C-Type | 3 | 2021 | 584 | 0.240 |
Why?
|
Base Sequence | 17 | 2020 | 12449 | 0.240 |
Why?
|
Skin Neoplasms | 3 | 2019 | 5820 | 0.240 |
Why?
|
Macromolecular Substances | 8 | 2004 | 1435 | 0.240 |
Why?
|
Immunocompetence | 2 | 2018 | 138 | 0.230 |
Why?
|
Tyrosine | 1 | 2008 | 1438 | 0.230 |
Why?
|
Endoplasmic Reticulum | 3 | 2005 | 1133 | 0.230 |
Why?
|
Dendritic Cells | 5 | 2020 | 2746 | 0.220 |
Why?
|
Azepines | 3 | 2020 | 329 | 0.220 |
Why?
|
Neoplasms, Experimental | 2 | 2019 | 1229 | 0.220 |
Why?
|
Neoadjuvant Therapy | 3 | 2024 | 2823 | 0.220 |
Why?
|
Gene Products, tax | 2 | 2001 | 51 | 0.210 |
Why?
|
Immunoassay | 1 | 2007 | 746 | 0.210 |
Why?
|
Receptors, Natural Killer Cell | 4 | 2007 | 57 | 0.210 |
Why?
|
Protein Interaction Domains and Motifs | 3 | 2018 | 452 | 0.210 |
Why?
|
Phosphorylation | 6 | 2023 | 8312 | 0.210 |
Why?
|
Interferon-gamma | 6 | 2022 | 3159 | 0.210 |
Why?
|
Complementarity Determining Regions | 4 | 2019 | 149 | 0.200 |
Why?
|
Antigen-Presenting Cells | 8 | 2014 | 964 | 0.200 |
Why?
|
Sequence Homology, Amino Acid | 5 | 2018 | 2749 | 0.200 |
Why?
|
Cell Proliferation | 9 | 2020 | 10431 | 0.190 |
Why?
|
Immunoblotting | 2 | 2017 | 1647 | 0.190 |
Why?
|
Antigens, Viral | 5 | 2018 | 987 | 0.190 |
Why?
|
alpha-Mannosidase | 1 | 2020 | 20 | 0.180 |
Why?
|
T-Cell Antigen Receptor Specificity | 3 | 2018 | 85 | 0.180 |
Why?
|
Transcription Factors | 4 | 2023 | 12122 | 0.180 |
Why?
|
Glutarates | 1 | 2022 | 243 | 0.180 |
Why?
|
HLA-A2 Antigen | 3 | 2003 | 211 | 0.180 |
Why?
|
Protein Structure, Secondary | 3 | 2013 | 1229 | 0.180 |
Why?
|
Microscopy, Fluorescence | 4 | 2019 | 2648 | 0.180 |
Why?
|
Clonal Anergy | 1 | 2001 | 171 | 0.180 |
Why?
|
Hepacivirus | 2 | 2008 | 1337 | 0.180 |
Why?
|
Core Binding Factor Alpha 3 Subunit | 1 | 2020 | 57 | 0.180 |
Why?
|
Periodicals as Topic | 1 | 2011 | 1463 | 0.180 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2021 | 197 | 0.180 |
Why?
|
Chaperonin 60 | 1 | 2000 | 97 | 0.180 |
Why?
|
Intercellular Adhesion Molecule-1 | 3 | 2014 | 1125 | 0.180 |
Why?
|
Primary Myelofibrosis | 1 | 2022 | 209 | 0.180 |
Why?
|
Chemokines, C | 1 | 2019 | 10 | 0.170 |
Why?
|
Amino Acid Motifs | 3 | 2008 | 931 | 0.170 |
Why?
|
Immunoglobulin A | 2 | 2019 | 980 | 0.170 |
Why?
|
Phenylenediamines | 1 | 2020 | 87 | 0.170 |
Why?
|
Central Nervous System Diseases | 2 | 1998 | 520 | 0.170 |
Why?
|
Cells, Cultured | 12 | 2021 | 18962 | 0.170 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2023 | 545 | 0.170 |
Why?
|
Cross-Priming | 1 | 2019 | 76 | 0.170 |
Why?
|
Glutamate Decarboxylase | 1 | 2000 | 239 | 0.170 |
Why?
|
Oncolytic Viruses | 1 | 2023 | 344 | 0.170 |
Why?
|
Sarcoma, Synovial | 1 | 2021 | 152 | 0.170 |
Why?
|
Phagocytes | 1 | 2021 | 296 | 0.160 |
Why?
|
Protein Precursors | 1 | 2003 | 1134 | 0.160 |
Why?
|
Cell Dedifferentiation | 1 | 2020 | 122 | 0.160 |
Why?
|
Receptors, CXCR3 | 1 | 2020 | 238 | 0.160 |
Why?
|
Static Electricity | 2 | 2012 | 261 | 0.160 |
Why?
|
Solubility | 6 | 2002 | 1091 | 0.160 |
Why?
|
Cricetulus | 2 | 2011 | 815 | 0.160 |
Why?
|
Neoplasm Transplantation | 2 | 2020 | 2014 | 0.160 |
Why?
|
Histone Code | 1 | 2020 | 158 | 0.160 |
Why?
|
Brain Neoplasms | 4 | 2023 | 9030 | 0.160 |
Why?
|
Gene Rearrangement, T-Lymphocyte | 2 | 1995 | 111 | 0.160 |
Why?
|
Gelatinases | 1 | 2018 | 88 | 0.160 |
Why?
|
Hemorrhagic Fever, American | 1 | 2018 | 12 | 0.160 |
Why?
|
Junin virus | 1 | 2018 | 13 | 0.160 |
Why?
|
Lipid Bilayers | 2 | 2012 | 383 | 0.160 |
Why?
|
Antigens, CD | 3 | 2018 | 4000 | 0.160 |
Why?
|
Acrylamides | 1 | 2020 | 259 | 0.160 |
Why?
|
Histone Deacetylase Inhibitors | 2 | 2021 | 774 | 0.160 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 2 | 2012 | 398 | 0.150 |
Why?
|
Arenaviruses, New World | 1 | 2018 | 35 | 0.150 |
Why?
|
CHO Cells | 2 | 2011 | 1389 | 0.150 |
Why?
|
HMGB Proteins | 1 | 2018 | 45 | 0.150 |
Why?
|
Recombinant Proteins | 10 | 2011 | 6525 | 0.150 |
Why?
|
Catalysis | 3 | 2010 | 774 | 0.150 |
Why?
|
Herpesvirus 1, Human | 1 | 2023 | 753 | 0.150 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 2019 | 303 | 0.150 |
Why?
|
Oncolytic Virotherapy | 1 | 2023 | 516 | 0.150 |
Why?
|
Gene Expression Profiling | 4 | 2021 | 9414 | 0.150 |
Why?
|
HTLV-I Infections | 4 | 2002 | 103 | 0.150 |
Why?
|
Acetylation | 1 | 2020 | 1054 | 0.140 |
Why?
|
Interleukin-2 | 7 | 2019 | 1891 | 0.140 |
Why?
|
Cricetinae | 2 | 2011 | 2427 | 0.140 |
Why?
|
Ependymoma | 1 | 2020 | 320 | 0.140 |
Why?
|
Multigene Family | 1 | 2020 | 1077 | 0.140 |
Why?
|
Gene Expression Regulation | 6 | 2021 | 11900 | 0.140 |
Why?
|
Gene Knock-In Techniques | 1 | 2018 | 421 | 0.140 |
Why?
|
Interferon Type I | 2 | 2019 | 562 | 0.140 |
Why?
|
Models, Chemical | 2 | 2010 | 611 | 0.140 |
Why?
|
Lysine | 2 | 2020 | 991 | 0.140 |
Why?
|
Protein Kinase C-epsilon | 1 | 2016 | 43 | 0.140 |
Why?
|
Intestines | 3 | 2020 | 1909 | 0.140 |
Why?
|
Immunity, Innate | 3 | 2019 | 3060 | 0.140 |
Why?
|
Mice, Inbred BALB C | 11 | 2022 | 6210 | 0.130 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 2018 | 445 | 0.130 |
Why?
|
Cholangiocarcinoma | 1 | 2022 | 552 | 0.130 |
Why?
|
Mice, SCID | 2 | 2020 | 2625 | 0.130 |
Why?
|
Bile Duct Neoplasms | 1 | 2022 | 605 | 0.130 |
Why?
|
Antibodies, Viral | 2 | 2018 | 3155 | 0.130 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2022 | 938 | 0.130 |
Why?
|
Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 2 | 1993 | 40 | 0.130 |
Why?
|
Oncogenes | 2 | 2021 | 1223 | 0.130 |
Why?
|
Biomedical Research | 1 | 2011 | 3429 | 0.130 |
Why?
|
Receptors, Androgen | 1 | 2022 | 1078 | 0.130 |
Why?
|
Myelin Proteolipid Protein | 3 | 2005 | 107 | 0.130 |
Why?
|
Transforming Growth Factor beta | 2 | 2020 | 1959 | 0.130 |
Why?
|
Immunity, Mucosal | 1 | 2019 | 483 | 0.130 |
Why?
|
Antigens, Bacterial | 2 | 1999 | 1155 | 0.130 |
Why?
|
Receptors, KIR | 2 | 2006 | 113 | 0.130 |
Why?
|
Polyglycolic Acid | 1 | 2017 | 405 | 0.130 |
Why?
|
Immune Evasion | 1 | 2019 | 363 | 0.130 |
Why?
|
Protein Engineering | 2 | 2011 | 550 | 0.120 |
Why?
|
Apoptosis | 4 | 2022 | 9474 | 0.120 |
Why?
|
Histones | 3 | 2020 | 2579 | 0.120 |
Why?
|
Mouth Neoplasms | 1 | 2020 | 596 | 0.120 |
Why?
|
Proteins | 2 | 2020 | 6034 | 0.120 |
Why?
|
Tumor Cells, Cultured | 3 | 2020 | 6128 | 0.120 |
Why?
|
Protein Kinase Inhibitors | 3 | 2021 | 5665 | 0.120 |
Why?
|
NFATC Transcription Factors | 1 | 2017 | 389 | 0.120 |
Why?
|
Endonucleases | 1 | 2018 | 369 | 0.120 |
Why?
|
Receptors, IgG | 1 | 2018 | 559 | 0.120 |
Why?
|
HEK293 Cells | 4 | 2020 | 4280 | 0.120 |
Why?
|
Pemphigus | 1 | 1995 | 116 | 0.120 |
Why?
|
HLA-DR4 Antigen | 2 | 2012 | 29 | 0.120 |
Why?
|
Viral Envelope Proteins | 1 | 2018 | 640 | 0.120 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2017 | 855 | 0.120 |
Why?
|
Oligodendroglia | 1 | 2018 | 538 | 0.110 |
Why?
|
Intestinal Mucosa | 3 | 2020 | 3027 | 0.110 |
Why?
|
Gene Knockdown Techniques | 2 | 2019 | 1611 | 0.110 |
Why?
|
Disease Models, Animal | 7 | 2021 | 18234 | 0.110 |
Why?
|
Cell Movement | 4 | 2014 | 5202 | 0.110 |
Why?
|
Oligopeptides | 1 | 1999 | 1186 | 0.110 |
Why?
|
Gene Rearrangement, delta-Chain T-Cell Antigen Receptor | 1 | 1993 | 15 | 0.110 |
Why?
|
Binding Sites, Antibody | 3 | 2018 | 337 | 0.110 |
Why?
|
Gene Silencing | 1 | 2020 | 1509 | 0.110 |
Why?
|
Kinetics | 4 | 2019 | 6374 | 0.110 |
Why?
|
Serine Endopeptidases | 1 | 2018 | 1021 | 0.110 |
Why?
|
Secretory Vesicles | 1 | 2014 | 128 | 0.110 |
Why?
|
Female | 41 | 2023 | 392485 | 0.110 |
Why?
|
HIV-1 | 2 | 2012 | 6860 | 0.110 |
Why?
|
Optic Neuritis | 1 | 2015 | 174 | 0.110 |
Why?
|
Models, Biological | 6 | 2020 | 9468 | 0.110 |
Why?
|
B-Lymphocyte Subsets | 1 | 2014 | 239 | 0.110 |
Why?
|
Stromal Cells | 1 | 2018 | 1330 | 0.110 |
Why?
|
Demyelinating Diseases | 3 | 2015 | 351 | 0.100 |
Why?
|
DNA Replication | 1 | 2020 | 1418 | 0.100 |
Why?
|
Stem Cells | 3 | 2020 | 3521 | 0.100 |
Why?
|
DNA Primers | 5 | 2011 | 2820 | 0.100 |
Why?
|
Lymph Nodes | 3 | 2020 | 3469 | 0.100 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2021 | 1605 | 0.100 |
Why?
|
Eukaryotic Initiation Factors | 1 | 2012 | 85 | 0.100 |
Why?
|
Carboxypeptidases | 1 | 2012 | 154 | 0.100 |
Why?
|
Surface Plasmon Resonance | 2 | 2010 | 268 | 0.100 |
Why?
|
Paraparesis, Tropical Spastic | 2 | 2007 | 32 | 0.100 |
Why?
|
Microscopy, Confocal | 3 | 2014 | 1968 | 0.100 |
Why?
|
Coculture Techniques | 3 | 2021 | 1341 | 0.100 |
Why?
|
Diabetes Mellitus, Experimental | 2 | 2017 | 1115 | 0.100 |
Why?
|
Central Nervous System Neoplasms | 1 | 2020 | 916 | 0.100 |
Why?
|
Mitosporic Fungi | 1 | 1991 | 17 | 0.100 |
Why?
|
Leucine Zippers | 3 | 2011 | 116 | 0.100 |
Why?
|
Hepatitis C | 3 | 2008 | 1584 | 0.100 |
Why?
|
Pleural Neoplasms | 1 | 2016 | 609 | 0.100 |
Why?
|
Lactic Acid | 1 | 2017 | 1137 | 0.100 |
Why?
|
Receptors, Cell Surface | 1 | 2021 | 2820 | 0.100 |
Why?
|
Indoles | 1 | 2019 | 1832 | 0.100 |
Why?
|
Phosphatidylserines | 1 | 2012 | 188 | 0.100 |
Why?
|
Promoter Regions, Genetic | 2 | 2020 | 5778 | 0.100 |
Why?
|
Oxygen | 1 | 2023 | 4227 | 0.100 |
Why?
|
Nervous System Diseases | 1 | 2002 | 1665 | 0.100 |
Why?
|
Immunosuppressive Agents | 2 | 2022 | 4173 | 0.090 |
Why?
|
Membrane Glycoproteins | 4 | 2018 | 3701 | 0.090 |
Why?
|
Food Microbiology | 1 | 1991 | 76 | 0.090 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2017 | 3806 | 0.090 |
Why?
|
Hydrogels | 1 | 2017 | 721 | 0.090 |
Why?
|
Polymorphism, Genetic | 5 | 2018 | 4286 | 0.090 |
Why?
|
Demyelinating Autoimmune Diseases, CNS | 2 | 2015 | 38 | 0.090 |
Why?
|
Ventricular Myosins | 1 | 2011 | 65 | 0.090 |
Why?
|
RNA, Double-Stranded | 1 | 2012 | 295 | 0.090 |
Why?
|
Structural Homology, Protein | 1 | 2011 | 87 | 0.090 |
Why?
|
Vaccination | 3 | 2023 | 3381 | 0.090 |
Why?
|
Cadherins | 1 | 1995 | 904 | 0.090 |
Why?
|
DNA Damage | 1 | 2021 | 2442 | 0.090 |
Why?
|
Cell Line | 11 | 2011 | 15599 | 0.090 |
Why?
|
Antibodies, Neutralizing | 2 | 2018 | 1943 | 0.090 |
Why?
|
Tissue Array Analysis | 1 | 2012 | 550 | 0.090 |
Why?
|
Tetanus Toxoid | 1 | 2011 | 193 | 0.090 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 3 | 2008 | 899 | 0.090 |
Why?
|
Antibody Specificity | 2 | 2011 | 1060 | 0.090 |
Why?
|
Cell Polarity | 1 | 2014 | 637 | 0.090 |
Why?
|
Mesothelioma | 1 | 2016 | 807 | 0.090 |
Why?
|
Multiprotein Complexes | 3 | 2007 | 1121 | 0.090 |
Why?
|
Directed Molecular Evolution | 1 | 2011 | 162 | 0.090 |
Why?
|
Neoplasm Proteins | 2 | 2019 | 3611 | 0.090 |
Why?
|
Myocarditis | 2 | 2011 | 786 | 0.090 |
Why?
|
Polysaccharides | 2 | 2020 | 1014 | 0.090 |
Why?
|
Macrophages | 2 | 2022 | 5768 | 0.090 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2019 | 2870 | 0.080 |
Why?
|
OX40 Ligand | 2 | 2020 | 55 | 0.080 |
Why?
|
Transduction, Genetic | 2 | 2019 | 901 | 0.080 |
Why?
|
Insulin | 2 | 2001 | 6595 | 0.080 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily C | 2 | 2007 | 35 | 0.080 |
Why?
|
Simplexvirus | 1 | 2013 | 803 | 0.080 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 11735 | 0.080 |
Why?
|
Neutrophils | 2 | 2019 | 3765 | 0.080 |
Why?
|
Phenotype | 6 | 2020 | 16603 | 0.080 |
Why?
|
Lymphoma | 1 | 2018 | 1901 | 0.080 |
Why?
|
Baculoviridae | 3 | 2011 | 115 | 0.080 |
Why?
|
Galectin 1 | 1 | 2009 | 128 | 0.080 |
Why?
|
Breast Neoplasms | 3 | 2021 | 21009 | 0.080 |
Why?
|
Spinal Cord | 2 | 2015 | 1817 | 0.070 |
Why?
|
Transfection | 5 | 2019 | 5776 | 0.070 |
Why?
|
Crystallization | 2 | 1999 | 533 | 0.070 |
Why?
|
Amino Acid Substitution | 5 | 2007 | 1737 | 0.070 |
Why?
|
Receptors, Interleukin-2 | 3 | 2005 | 562 | 0.070 |
Why?
|
Radioimmunoassay | 2 | 2005 | 866 | 0.070 |
Why?
|
Hybridomas | 3 | 2011 | 442 | 0.070 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2011 | 651 | 0.070 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2010 | 1693 | 0.070 |
Why?
|
Photolysis | 1 | 2007 | 94 | 0.070 |
Why?
|
Transgenes | 1 | 2010 | 1009 | 0.070 |
Why?
|
Neovascularization, Pathologic | 1 | 2017 | 2644 | 0.070 |
Why?
|
Gene Knockout Techniques | 2 | 2021 | 802 | 0.070 |
Why?
|
Transmembrane Activator and CAML Interactor Protein | 1 | 2007 | 55 | 0.070 |
Why?
|
Nanotechnology | 1 | 2012 | 712 | 0.070 |
Why?
|
Photochemistry | 1 | 2007 | 239 | 0.070 |
Why?
|
Epithelial Cells | 1 | 2019 | 3666 | 0.070 |
Why?
|
DNA-Binding Proteins | 6 | 2018 | 9605 | 0.070 |
Why?
|
Ovarian Neoplasms | 1 | 2023 | 4877 | 0.070 |
Why?
|
Multiple Myeloma | 1 | 2024 | 5146 | 0.070 |
Why?
|
Transcription, Genetic | 1 | 2020 | 7597 | 0.070 |
Why?
|
Hydrogen Bonding | 1 | 2006 | 291 | 0.070 |
Why?
|
RNA, Messenger | 6 | 2012 | 12787 | 0.070 |
Why?
|
Common Variable Immunodeficiency | 1 | 2007 | 102 | 0.070 |
Why?
|
src-Family Kinases | 1 | 2008 | 535 | 0.070 |
Why?
|
Blood Cells | 2 | 2005 | 304 | 0.070 |
Why?
|
Protein Multimerization | 1 | 2011 | 983 | 0.060 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2022 | 3613 | 0.060 |
Why?
|
Fluoroimmunoassay | 1 | 2005 | 30 | 0.060 |
Why?
|
Beverages | 1 | 1991 | 821 | 0.060 |
Why?
|
Fruit | 1 | 1991 | 1160 | 0.060 |
Why?
|
Protein Folding | 2 | 2007 | 869 | 0.060 |
Why?
|
Receptors, Collagen | 1 | 2005 | 25 | 0.060 |
Why?
|
HIV Core Protein p24 | 1 | 2005 | 245 | 0.060 |
Why?
|
Spodoptera | 2 | 2011 | 141 | 0.060 |
Why?
|
HIV Infections | 3 | 2014 | 17346 | 0.060 |
Why?
|
Myelin Sheath | 1 | 2009 | 653 | 0.060 |
Why?
|
Calcium | 2 | 2017 | 5726 | 0.060 |
Why?
|
Enterotoxins | 1 | 2007 | 367 | 0.060 |
Why?
|
Male | 27 | 2022 | 360621 | 0.060 |
Why?
|
Microsomes | 1 | 2005 | 251 | 0.060 |
Why?
|
Th17 Cells | 1 | 2011 | 793 | 0.060 |
Why?
|
Pancreatic Neoplasms | 1 | 2023 | 5363 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2006 | 2897 | 0.060 |
Why?
|
Tissue Culture Techniques | 2 | 2019 | 290 | 0.060 |
Why?
|
Cell Survival | 4 | 2017 | 5792 | 0.060 |
Why?
|
Up-Regulation | 3 | 2020 | 4120 | 0.060 |
Why?
|
Pseudomonas aeruginosa | 1 | 2013 | 1279 | 0.060 |
Why?
|
Genetic Linkage | 2 | 2003 | 2382 | 0.060 |
Why?
|
Solutions | 1 | 2005 | 412 | 0.060 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2008 | 694 | 0.060 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2014 | 3638 | 0.060 |
Why?
|
Triazoles | 2 | 2020 | 903 | 0.060 |
Why?
|
RNA, Small Interfering | 1 | 2014 | 3428 | 0.060 |
Why?
|
Genetic Testing | 1 | 2018 | 3538 | 0.060 |
Why?
|
Protein Structure, Quaternary | 1 | 2005 | 429 | 0.060 |
Why?
|
HLA-DP Antigens | 1 | 2003 | 28 | 0.060 |
Why?
|
Aspartic Acid | 1 | 2006 | 576 | 0.060 |
Why?
|
Graft vs Host Disease | 1 | 2017 | 3030 | 0.060 |
Why?
|
Cytoplasm | 1 | 2008 | 1511 | 0.060 |
Why?
|
Fibroblasts | 1 | 2014 | 4139 | 0.060 |
Why?
|
Peripheral Nervous System Diseases | 1 | 1990 | 710 | 0.060 |
Why?
|
Polymerase Chain Reaction | 6 | 1992 | 6086 | 0.060 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2006 | 509 | 0.060 |
Why?
|
Immunomagnetic Separation | 1 | 2003 | 79 | 0.060 |
Why?
|
Neuroglia | 1 | 2009 | 955 | 0.050 |
Why?
|
Age Distribution | 1 | 2009 | 2880 | 0.050 |
Why?
|
Recombinant Fusion Proteins | 3 | 2004 | 3734 | 0.050 |
Why?
|
Precipitin Tests | 1 | 2004 | 815 | 0.050 |
Why?
|
Rats, Inbred ACI | 1 | 2022 | 34 | 0.050 |
Why?
|
Homeostasis | 1 | 2014 | 3322 | 0.050 |
Why?
|
Reproducibility of Results | 3 | 2023 | 20092 | 0.050 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 2005 | 280 | 0.050 |
Why?
|
Transplantation Tolerance | 1 | 2008 | 605 | 0.050 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 1745 | 0.050 |
Why?
|
History, 20th Century | 1 | 2010 | 2770 | 0.050 |
Why?
|
Antigens, Protozoan | 2 | 2004 | 316 | 0.050 |
Why?
|
Spondylitis, Ankylosing | 1 | 2004 | 152 | 0.050 |
Why?
|
Mutagenesis | 1 | 2006 | 1232 | 0.050 |
Why?
|
gag Gene Products, Human Immunodeficiency Virus | 2 | 2014 | 206 | 0.050 |
Why?
|
Age of Onset | 1 | 2009 | 3303 | 0.050 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 1 | 2003 | 244 | 0.050 |
Why?
|
Antibody Affinity | 1 | 2003 | 246 | 0.050 |
Why?
|
Ultraviolet Rays | 1 | 2007 | 1079 | 0.050 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2010 | 3768 | 0.050 |
Why?
|
Oncostatin M Receptor beta Subunit | 1 | 2021 | 4 | 0.050 |
Why?
|
Gliadin | 1 | 2001 | 80 | 0.050 |
Why?
|
Haplotypes | 3 | 2001 | 2774 | 0.050 |
Why?
|
Leukemia Inhibitory Factor Receptor alpha Subunit | 1 | 2021 | 30 | 0.050 |
Why?
|
Cytokine Receptor gp130 | 1 | 2021 | 66 | 0.050 |
Why?
|
Oncostatin M | 1 | 2021 | 42 | 0.050 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2022 | 411 | 0.050 |
Why?
|
Bacterial Toxins | 1 | 2007 | 932 | 0.050 |
Why?
|
Light | 1 | 2007 | 1351 | 0.050 |
Why?
|
Disease Susceptibility | 3 | 2005 | 1791 | 0.050 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2006 | 973 | 0.050 |
Why?
|
Dexamethasone | 2 | 2018 | 1946 | 0.050 |
Why?
|
Influenza A virus | 1 | 2004 | 457 | 0.050 |
Why?
|
Genes, myc | 1 | 2022 | 390 | 0.050 |
Why?
|
Leishmania major | 1 | 2000 | 59 | 0.050 |
Why?
|
Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 2 | 1991 | 94 | 0.050 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2022 | 296 | 0.040 |
Why?
|
Oligodeoxyribonucleotides | 2 | 1993 | 779 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2017 | 6478 | 0.040 |
Why?
|
Saccharomyces cerevisiae | 1 | 2011 | 2687 | 0.040 |
Why?
|
Alleles | 3 | 2007 | 6909 | 0.040 |
Why?
|
Immunoglobulin G | 3 | 2019 | 4550 | 0.040 |
Why?
|
Azides | 1 | 2020 | 118 | 0.040 |
Why?
|
Virus Replication | 2 | 2005 | 2435 | 0.040 |
Why?
|
Interleukin-4 | 2 | 1995 | 1149 | 0.040 |
Why?
|
Piperazines | 2 | 2021 | 2519 | 0.040 |
Why?
|
Cysteine | 1 | 2004 | 892 | 0.040 |
Why?
|
Click Chemistry | 1 | 2020 | 95 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 7 | 2018 | 17872 | 0.040 |
Why?
|
Ploidies | 1 | 2020 | 284 | 0.040 |
Why?
|
Staining and Labeling | 2 | 2020 | 1085 | 0.040 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2011 | 1640 | 0.040 |
Why?
|
raf Kinases | 1 | 2019 | 118 | 0.040 |
Why?
|
Prostatic Neoplasms | 1 | 2022 | 11116 | 0.040 |
Why?
|
Survival Analysis | 2 | 2023 | 10075 | 0.040 |
Why?
|
Breast Neoplasms, Male | 1 | 2021 | 219 | 0.040 |
Why?
|
Amino Acids | 2 | 2002 | 1718 | 0.040 |
Why?
|
Antineoplastic Agents | 2 | 2020 | 13635 | 0.040 |
Why?
|
Leishmaniasis, Cutaneous | 1 | 2000 | 136 | 0.040 |
Why?
|
Mutation | 5 | 2020 | 30044 | 0.040 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 1 | 2004 | 555 | 0.040 |
Why?
|
Gene Expression | 3 | 1998 | 7582 | 0.040 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2003 | 2498 | 0.040 |
Why?
|
Protozoan Proteins | 2 | 2004 | 846 | 0.040 |
Why?
|
Pyridines | 2 | 2021 | 2870 | 0.040 |
Why?
|
Somatic Hypermutation, Immunoglobulin | 1 | 2019 | 101 | 0.040 |
Why?
|
Neoplasm, Residual | 1 | 2023 | 1008 | 0.040 |
Why?
|
Pentoxifylline | 1 | 1998 | 53 | 0.040 |
Why?
|
Antibody Formation | 1 | 2003 | 1397 | 0.040 |
Why?
|
4-1BB Ligand | 1 | 2018 | 29 | 0.040 |
Why?
|
Adhesins, Bacterial | 1 | 1998 | 118 | 0.040 |
Why?
|
Myocardium | 1 | 2011 | 4723 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase 7 | 1 | 2018 | 66 | 0.040 |
Why?
|
DNA Modification Methylases | 1 | 2018 | 210 | 0.040 |
Why?
|
Islets of Langerhans | 1 | 2004 | 1346 | 0.040 |
Why?
|
Encephalitis | 2 | 1999 | 438 | 0.040 |
Why?
|
Bystander Effect | 1 | 2018 | 90 | 0.040 |
Why?
|
Granzymes | 1 | 2019 | 277 | 0.040 |
Why?
|
Immune Sera | 1 | 2018 | 613 | 0.040 |
Why?
|
Herpes Simplex | 1 | 2001 | 478 | 0.040 |
Why?
|
Immunoglobulin Variable Region | 1 | 2019 | 419 | 0.040 |
Why?
|
Rats | 4 | 2022 | 23729 | 0.040 |
Why?
|
Lipids | 1 | 2008 | 3341 | 0.040 |
Why?
|
Blood Donors | 1 | 2019 | 345 | 0.040 |
Why?
|
Aminopyridines | 1 | 2021 | 573 | 0.040 |
Why?
|
Toll-Like Receptor 8 | 1 | 2017 | 98 | 0.040 |
Why?
|
Influenza Vaccines | 1 | 2004 | 767 | 0.040 |
Why?
|
Conserved Sequence | 1 | 2000 | 1164 | 0.040 |
Why?
|
Immunity | 1 | 2023 | 997 | 0.040 |
Why?
|
Liver | 1 | 1993 | 7531 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2019 | 641 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2021 | 870 | 0.030 |
Why?
|
DNA Repair Enzymes | 1 | 2018 | 346 | 0.030 |
Why?
|
Serpins | 1 | 2018 | 247 | 0.030 |
Why?
|
Drug Compounding | 1 | 2018 | 246 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2022 | 988 | 0.030 |
Why?
|
Receptors, Transferrin | 1 | 2018 | 291 | 0.030 |
Why?
|
Telomerase | 1 | 2001 | 745 | 0.030 |
Why?
|
Middle Aged | 11 | 2021 | 220774 | 0.030 |
Why?
|
Metalloendopeptidases | 1 | 1998 | 393 | 0.030 |
Why?
|
Retinoblastoma Protein | 1 | 2020 | 671 | 0.030 |
Why?
|
Toll-Like Receptor 7 | 1 | 2017 | 177 | 0.030 |
Why?
|
Endosomes | 1 | 1999 | 522 | 0.030 |
Why?
|
Bone Marrow | 2 | 2022 | 2909 | 0.030 |
Why?
|
Acute Disease | 3 | 2014 | 7238 | 0.030 |
Why?
|
Desmoglein 3 | 1 | 1995 | 9 | 0.030 |
Why?
|
Forkhead Transcription Factors | 2 | 2018 | 1612 | 0.030 |
Why?
|
Aged | 9 | 2021 | 169179 | 0.030 |
Why?
|
Hypoglycemic Agents | 1 | 2009 | 3082 | 0.030 |
Why?
|
Injections, Subcutaneous | 1 | 1997 | 680 | 0.030 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2018 | 367 | 0.030 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2019 | 649 | 0.030 |
Why?
|
Phagocytosis | 1 | 2022 | 1536 | 0.030 |
Why?
|
Drug Synergism | 1 | 2020 | 1757 | 0.030 |
Why?
|
Cell Differentiation | 3 | 2022 | 11531 | 0.030 |
Why?
|
Polymers | 2 | 2003 | 1614 | 0.030 |
Why?
|
Benzimidazoles | 1 | 2021 | 858 | 0.030 |
Why?
|
Pericytes | 1 | 2018 | 293 | 0.030 |
Why?
|
Blood-Brain Barrier | 1 | 2002 | 1025 | 0.030 |
Why?
|
Plasma Cells | 1 | 2019 | 599 | 0.030 |
Why?
|
Hydroxamic Acids | 1 | 1998 | 481 | 0.030 |
Why?
|
Injections, Intravenous | 1 | 1997 | 1379 | 0.030 |
Why?
|
Mice, Inbred DBA | 3 | 2001 | 621 | 0.030 |
Why?
|
T-Box Domain Proteins | 1 | 2018 | 468 | 0.030 |
Why?
|
Transcriptional Activation | 2 | 2020 | 1753 | 0.030 |
Why?
|
Models, Theoretical | 1 | 2007 | 3577 | 0.030 |
Why?
|
Fibrosis | 1 | 2022 | 2048 | 0.030 |
Why?
|
Brain | 3 | 2015 | 27103 | 0.030 |
Why?
|
Antigenic Variation | 1 | 1995 | 118 | 0.030 |
Why?
|
Endopeptidases | 1 | 2018 | 773 | 0.030 |
Why?
|
DNA, Neoplasm | 1 | 2020 | 1745 | 0.030 |
Why?
|
Receptors, Virus | 1 | 2018 | 640 | 0.030 |
Why?
|
Protein Subunits | 1 | 2018 | 942 | 0.030 |
Why?
|
Protease Inhibitors | 1 | 1998 | 753 | 0.030 |
Why?
|
Green Fluorescent Proteins | 2 | 2012 | 2062 | 0.030 |
Why?
|
Homeodomain Proteins | 1 | 2023 | 2413 | 0.030 |
Why?
|
B-Cell Activating Factor | 1 | 2014 | 115 | 0.030 |
Why?
|
Aquaporin 4 | 1 | 2015 | 161 | 0.030 |
Why?
|
Antibodies | 2 | 2019 | 2421 | 0.030 |
Why?
|
Immunologic Surveillance | 1 | 1994 | 92 | 0.030 |
Why?
|
Virus Release | 1 | 2014 | 38 | 0.030 |
Why?
|
Prostate | 1 | 2022 | 1770 | 0.030 |
Why?
|
Fungal Proteins | 1 | 1998 | 910 | 0.030 |
Why?
|
Cell Line, Transformed | 1 | 1995 | 868 | 0.030 |
Why?
|
Cell Death | 1 | 2019 | 1674 | 0.030 |
Why?
|
Celiac Disease | 1 | 2001 | 825 | 0.030 |
Why?
|
Drosophila melanogaster | 2 | 2000 | 1711 | 0.030 |
Why?
|
pol Gene Products, Human Immunodeficiency Virus | 1 | 2012 | 39 | 0.030 |
Why?
|
Blotting, Southern | 2 | 1991 | 780 | 0.030 |
Why?
|
Peptide Library | 1 | 2014 | 347 | 0.030 |
Why?
|
Safety | 1 | 1997 | 1150 | 0.030 |
Why?
|
Monocytes | 1 | 2022 | 2573 | 0.030 |
Why?
|
Haptoglobins | 1 | 2014 | 167 | 0.030 |
Why?
|
Nylons | 1 | 2012 | 46 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2022 | 2859 | 0.030 |
Why?
|
Viral Vaccines | 1 | 2018 | 596 | 0.030 |
Why?
|
Endosomal Sorting Complexes Required for Transport | 1 | 2014 | 150 | 0.030 |
Why?
|
Paclitaxel | 1 | 2020 | 1732 | 0.030 |
Why?
|
HTLV-I Antibodies | 1 | 1992 | 35 | 0.030 |
Why?
|
Age Factors | 1 | 2009 | 18401 | 0.030 |
Why?
|
NF-kappa B | 1 | 2021 | 2488 | 0.030 |
Why?
|
Endothelium, Lymphatic | 1 | 2012 | 63 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-vav | 1 | 2012 | 91 | 0.030 |
Why?
|
Myosin Light Chains | 1 | 2012 | 121 | 0.030 |
Why?
|
Genetic Engineering | 1 | 2018 | 933 | 0.030 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2022 | 2821 | 0.030 |
Why?
|
Adult | 9 | 2021 | 221122 | 0.030 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2020 | 1249 | 0.030 |
Why?
|
Cell Adhesion Molecules | 1 | 1998 | 1600 | 0.020 |
Why?
|
Dimethylpolysiloxanes | 1 | 2012 | 142 | 0.020 |
Why?
|
Viral Load | 2 | 2014 | 3330 | 0.020 |
Why?
|
Immunohistochemistry | 4 | 2007 | 11070 | 0.020 |
Why?
|
Galactans | 1 | 1991 | 31 | 0.020 |
Why?
|
Radiotherapy | 1 | 2018 | 1499 | 0.020 |
Why?
|
Child | 4 | 2020 | 80156 | 0.020 |
Why?
|
Luminescent Proteins | 1 | 2014 | 836 | 0.020 |
Why?
|
Imidazoles | 1 | 2017 | 1179 | 0.020 |
Why?
|
Chromatography, Gas | 1 | 1991 | 151 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2022 | 8166 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2007 | 14665 | 0.020 |
Why?
|
Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2012 | 158 | 0.020 |
Why?
|
Glucans | 1 | 1991 | 68 | 0.020 |
Why?
|
Colloids | 1 | 1991 | 122 | 0.020 |
Why?
|
Chromatography, Ion Exchange | 1 | 1991 | 296 | 0.020 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2012 | 234 | 0.020 |
Why?
|
env Gene Products, Human Immunodeficiency Virus | 1 | 2014 | 369 | 0.020 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2012 | 242 | 0.020 |
Why?
|
Vesicular Transport Proteins | 1 | 2014 | 376 | 0.020 |
Why?
|
Carbohydrate Sequence | 1 | 1991 | 411 | 0.020 |
Why?
|
Autophagy | 1 | 2019 | 1321 | 0.020 |
Why?
|
Cardiac Myosins | 1 | 2011 | 128 | 0.020 |
Why?
|
Proviruses | 1 | 1992 | 313 | 0.020 |
Why?
|
Interleukin-10 | 1 | 1995 | 1175 | 0.020 |
Why?
|
Lymphoid Tissue | 1 | 2011 | 445 | 0.020 |
Why?
|
Adoptive Transfer | 2 | 2004 | 819 | 0.020 |
Why?
|
Immunity, Humoral | 1 | 2014 | 605 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2020 | 58946 | 0.020 |
Why?
|
HIV Envelope Protein gp120 | 1 | 2014 | 914 | 0.020 |
Why?
|
Child, Preschool | 3 | 2009 | 42251 | 0.020 |
Why?
|
Microglia | 2 | 1998 | 1357 | 0.020 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 1999 | 1841 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2017 | 3588 | 0.020 |
Why?
|
Time Factors | 2 | 2011 | 39974 | 0.020 |
Why?
|
Myosin Heavy Chains | 1 | 2011 | 404 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 1992 | 1704 | 0.020 |
Why?
|
Molecular Weight | 1 | 1991 | 2188 | 0.020 |
Why?
|
Platelet Activation | 1 | 2012 | 645 | 0.020 |
Why?
|
Computational Biology | 1 | 2021 | 3512 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2023 | 64645 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2020 | 3448 | 0.020 |
Why?
|
Mesenchymal Stem Cells | 1 | 2019 | 1642 | 0.020 |
Why?
|
Injections, Intraperitoneal | 1 | 2009 | 412 | 0.020 |
Why?
|
Polyneuropathies | 1 | 1990 | 137 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2018 | 2804 | 0.020 |
Why?
|
Nuclear Proteins | 2 | 2020 | 5794 | 0.020 |
Why?
|
H-Y Antigen | 1 | 2008 | 42 | 0.020 |
Why?
|
HTLV-I Antigens | 1 | 2007 | 7 | 0.020 |
Why?
|
Genes, pX | 1 | 2007 | 7 | 0.020 |
Why?
|
Young Adult | 2 | 2018 | 59196 | 0.020 |
Why?
|
Interleukin-1 | 1 | 1992 | 1250 | 0.020 |
Why?
|
Heat-Shock Proteins | 1 | 1992 | 796 | 0.020 |
Why?
|
Genome, Viral | 1 | 1992 | 665 | 0.020 |
Why?
|
Chronic Disease | 2 | 2014 | 9319 | 0.020 |
Why?
|
Protein Transport | 1 | 2014 | 1967 | 0.020 |
Why?
|
Adolescent | 4 | 2015 | 88305 | 0.020 |
Why?
|
Chimerin Proteins | 1 | 2007 | 6 | 0.020 |
Why?
|
Receptors, CXCR4 | 1 | 2012 | 727 | 0.020 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily D | 1 | 2007 | 30 | 0.020 |
Why?
|
Pan troglodytes | 1 | 2008 | 225 | 0.020 |
Why?
|
Adaptive Immunity | 1 | 2012 | 725 | 0.020 |
Why?
|
HIV Antibodies | 1 | 2014 | 1303 | 0.020 |
Why?
|
Crystallography | 1 | 2007 | 116 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2017 | 2650 | 0.020 |
Why?
|
Molecular Structure | 1 | 1991 | 1878 | 0.020 |
Why?
|
RNA | 2 | 1998 | 2723 | 0.020 |
Why?
|
HIV | 1 | 2014 | 1582 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2018 | 8526 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2012 | 1675 | 0.020 |
Why?
|
HeLa Cells | 1 | 2012 | 3097 | 0.020 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2004 | 5670 | 0.020 |
Why?
|
Drug Delivery Systems | 1 | 2017 | 2223 | 0.020 |
Why?
|
Statistics, Nonparametric | 2 | 2004 | 2853 | 0.020 |
Why?
|
Nanoparticles | 1 | 2017 | 1955 | 0.020 |
Why?
|
Cell Lineage | 2 | 2004 | 2556 | 0.020 |
Why?
|
Aggrecans | 1 | 2004 | 89 | 0.020 |
Why?
|
Actins | 1 | 2012 | 2051 | 0.020 |
Why?
|
Ribavirin | 1 | 2006 | 395 | 0.010 |
Why?
|
DNA Methylation | 1 | 2018 | 4383 | 0.010 |
Why?
|
Genomics | 1 | 2020 | 5817 | 0.010 |
Why?
|
Lentivirus | 1 | 2007 | 508 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2022 | 9275 | 0.010 |
Why?
|
Solvents | 1 | 2004 | 294 | 0.010 |
Why?
|
Arthritis, Rheumatoid | 1 | 1999 | 3760 | 0.010 |
Why?
|
Theilovirus | 1 | 2003 | 11 | 0.010 |
Why?
|
Lymphocyte Transfusion | 1 | 2004 | 232 | 0.010 |
Why?
|
Crosses, Genetic | 1 | 2004 | 751 | 0.010 |
Why?
|
Neuraminidase | 1 | 2003 | 199 | 0.010 |
Why?
|
Skin Transplantation | 1 | 2008 | 1083 | 0.010 |
Why?
|
Disease Progression | 1 | 2019 | 13500 | 0.010 |
Why?
|
Fluorescein | 1 | 2002 | 175 | 0.010 |
Why?
|
Interferon-alpha | 1 | 2006 | 921 | 0.010 |
Why?
|
Retroviridae | 1 | 2004 | 850 | 0.010 |
Why?
|
Point Mutation | 1 | 2007 | 1595 | 0.010 |
Why?
|
Blood Platelets | 1 | 2012 | 2481 | 0.010 |
Why?
|
Insulin-Secreting Cells | 1 | 2009 | 900 | 0.010 |
Why?
|
Proteoglycans | 1 | 2004 | 803 | 0.010 |
Why?
|
Staphylococcal Protein A | 1 | 2000 | 39 | 0.010 |
Why?
|
Neurons | 1 | 2020 | 9458 | 0.010 |
Why?
|
Serine | 1 | 2004 | 829 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 1 | 2007 | 1842 | 0.010 |
Why?
|
Lung | 1 | 2019 | 9994 | 0.010 |
Why?
|
Extracellular Matrix Proteins | 1 | 2004 | 828 | 0.010 |
Why?
|
Vero Cells | 1 | 2001 | 482 | 0.010 |
Why?
|
Heterozygote | 1 | 2007 | 2803 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 2003 | 1759 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2008 | 2693 | 0.010 |
Why?
|
Virulence Factors, Bordetella | 1 | 1999 | 154 | 0.010 |
Why?
|
Pertussis Toxin | 1 | 1999 | 176 | 0.010 |
Why?
|
Freund's Adjuvant | 1 | 1999 | 148 | 0.010 |
Why?
|
Prognosis | 1 | 2020 | 29588 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2012 | 3543 | 0.010 |
Why?
|
Databases, Factual | 1 | 1995 | 7954 | 0.010 |
Why?
|
Glycoproteins | 1 | 2007 | 2207 | 0.010 |
Why?
|
Immunocompromised Host | 1 | 2004 | 856 | 0.010 |
Why?
|
Yersinia | 1 | 1998 | 9 | 0.010 |
Why?
|
Titrimetry | 1 | 1998 | 35 | 0.010 |
Why?
|
Genes, Immunoglobulin | 1 | 1999 | 285 | 0.010 |
Why?
|
Aminopeptidases | 1 | 1999 | 95 | 0.010 |
Why?
|
Integrin alpha3beta1 | 1 | 1998 | 53 | 0.010 |
Why?
|
Benzyl Compounds | 1 | 1998 | 20 | 0.010 |
Why?
|
Skin | 1 | 2012 | 4482 | 0.010 |
Why?
|
Succinates | 1 | 1998 | 81 | 0.010 |
Why?
|
Biological Transport | 1 | 2003 | 2090 | 0.010 |
Why?
|
Anti-HIV Agents | 1 | 2014 | 4524 | 0.010 |
Why?
|
Leukemia, Erythroblastic, Acute | 1 | 1998 | 176 | 0.010 |
Why?
|
Glutamic Acid | 1 | 2003 | 1176 | 0.010 |
Why?
|
Spleen | 1 | 2004 | 2296 | 0.010 |
Why?
|
Organic Chemicals | 1 | 1998 | 211 | 0.010 |
Why?
|
Oncogene Proteins, Viral | 1 | 1998 | 340 | 0.010 |
Why?
|
Guinea Pigs | 1 | 1998 | 1317 | 0.010 |
Why?
|
Cell Communication | 1 | 2004 | 1657 | 0.010 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 1998 | 552 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2004 | 1974 | 0.010 |
Why?
|
Immunization, Passive | 1 | 1998 | 616 | 0.010 |
Why?
|
Cloning, Molecular | 2 | 1994 | 4175 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1999 | 1540 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2005 | 2637 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 1998 | 2560 | 0.010 |
Why?
|
Optic Nerve | 1 | 1998 | 572 | 0.010 |
Why?
|
Cytomegalovirus | 1 | 1998 | 756 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2006 | 3057 | 0.010 |
Why?
|
Algorithms | 1 | 2014 | 14025 | 0.010 |
Why?
|
Polyenes | 1 | 1992 | 68 | 0.010 |
Why?
|
Papillomaviridae | 1 | 1998 | 1119 | 0.010 |
Why?
|
Drug Combinations | 1 | 1998 | 2048 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 1998 | 3419 | 0.010 |
Why?
|
Hematopoietic Stem Cells | 1 | 2004 | 3396 | 0.010 |
Why?
|
Oligonucleotide Probes | 1 | 1991 | 417 | 0.010 |
Why?
|
Down-Regulation | 1 | 1998 | 2913 | 0.010 |
Why?
|
Drosophila | 1 | 1998 | 1495 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2011 | 26211 | 0.010 |
Why?
|
Pregnancy | 1 | 2012 | 29858 | 0.010 |
Why?
|
Astrocytes | 1 | 1998 | 1346 | 0.010 |
Why?
|
Blood Glucose | 1 | 2004 | 6389 | 0.010 |
Why?
|
Serotonin | 1 | 1994 | 1041 | 0.010 |
Why?
|
DNA Probes | 1 | 1991 | 544 | 0.010 |
Why?
|
Cyclosporine | 1 | 1992 | 778 | 0.010 |
Why?
|
Jejunum | 1 | 1991 | 472 | 0.010 |
Why?
|
Antigens, CD1 | 1 | 1991 | 439 | 0.000 |
Why?
|
Infant | 1 | 2011 | 36202 | 0.000 |
Why?
|
Genetic Vectors | 1 | 1998 | 3393 | 0.000 |
Why?
|
Tacrolimus | 1 | 1992 | 733 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 36430 | 0.000 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 1998 | 4355 | 0.000 |
Why?
|
Epithelium | 1 | 1991 | 1603 | 0.000 |
Why?
|
Recurrence | 1 | 1998 | 8470 | 0.000 |
Why?
|
Sirolimus | 1 | 1992 | 1533 | 0.000 |
Why?
|
DNA | 1 | 1988 | 7216 | 0.000 |
Why?
|